<ѻý>Tirzepatide Fast-Tracked for Weight Loss; Geographical PCOS; New AID Guidelinesѻý> News and commentary from the endocrinology world Oct 11, 2022
<ѻý>SGLT2 Inhibitors, GLP-1 RAs Not Cost-Effective as First-Line T2D Agentsѻý> Cost-effectiveness study compared lifetime costs with first-line metformin Oct 03, 2022
<ѻý>Incidence of Dry Eye Disease Lower With SGLT2 Inhibitorsѻý> Retrospective study in Taiwan reported 22% risk reduction compared with GLP-1 receptor agonists Sep 24, 2022
<ѻý>Women With Type 2 Diabetes Die Sooner Than Men, Study Suggestsѻý> Other groups at risk for early mortality include smokers, those diagnosed at younger ages Sep 23, 2022
<ѻý>Hysterectomy: Another Diabetes Risk Factor?ѻý> Preservation of ovaries played into this association Sep 22, 2022
<ѻý>Eye Damage Can Start in Prediabetesѻý> Study found significant corneal nerve damage even before full-blown type 2 diabetes Sep 22, 2022
<ѻý>Our Hands Are Tied: Treating Prediabetes in Kidsѻý> We urgently need more research on pharmacological interventions for this growing epidemic Sep 14, 2022
<ѻý>Do Some ѻý Need to Get Better at Documenting Hypertension in Patient Notes?ѻý> Study finds settings where BP documentation is especially lax Sep 11, 2022
<ѻý>ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos?ѻý> News and commentary from the endocrinology world Sep 07, 2022
<ѻý>Prescribing of Newer Diabetes Drugs Not Up to Snuff in Black Patients?ѻý> Study among veterans suggests disparities in prescription rates for these type 2 diabetes drugs Sep 06, 2022
<ѻý>Racial Differences in Bariatric Surgery Safety Persistѻý> Minority groups saw more weight loss with one procedure, but also more complications Aug 31, 2022
<ѻý>FDA Data Link Diabetes Drug Class to Gallbladder Diseaseѻý> FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists Aug 30, 2022
<ѻý>How Have Glucagon Costs Changed in Recent Years?ѻý> Wholesale costs spiked from 2010 to 2020, but out-of-pocket prices remained mostly stable Aug 30, 2022
<ѻý>Mass Cardiovascular Testing May Add Years for Some Menѻý> Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
<ѻý>Combining Common Diabetic Nerve Pain Drugs Helped Provide More Reliefѻý> No specific combination stood out among the crowd Aug 24, 2022
<ѻý>Can Lower Gestational Diabetes Cutoff Improve Outcomes in Kids?ѻý> About 9% of babies born large for gestational age regardless of the approach to diagnosis Aug 17, 2022
<ѻý>Minimally Invasive Bariatric Procedure Effective for Milder Obesityѻý> Big weight loss seen in patients with mild and moderate levels of obesity Aug 02, 2022
<ѻý>Dear Insurers: It's Time to Cover Weight Loss Drugsѻý> Universal coverage can increase medication access and improve population health Jul 27, 2022
<ѻý>'Senolytic' Therapy Shows Promise in Neovascular Eye Diseaseѻý> Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
<ѻý>Keto Versus Mediterranean Diet: Which Is Better for Diabetes?ѻý> Crossover study looked at cardiometabolic outcomes for each popular diet Jul 08, 2022
<ѻý>Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleepѻý> New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
<ѻý>EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2Dѻý> Noteworthy research from the European Association for the Study of the Liver annual meeting Jun 29, 2022
<ѻý>Primary Care Screening Flops in Detecting Diabetic Eye Diseaseѻý> Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
<ѻý>Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosisѻý> Randomized trial showed improvements in cardiometabolic markers, but not liver fibrosis Jun 27, 2022
<ѻý>Gastric Bypass Edges Out Sleeve Gastrectomy for 10-Year Outcomesѻý> Randomized trial compared the two popular bariatric surgeries Jun 22, 2022
<ѻý>Diabetes Threatens Long-Term Survival in Metastatic Breast Cancerѻý> 5-year survival rates were not affected, however Jun 13, 2022
<ѻý>Prediabetes May Be an Independent Risk Factor for MIѻý> Findings reinforce importance of early screening and intervention, researchers says Jun 12, 2022
<ѻý>ADA 2022: Racial Residential Segregation, DKA During COVID, and Moreѻý> Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
<ѻý>Concerning Trends in Vision Impairment for Adults With Diabetes?ѻý> Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
<ѻý>Tirzepatide Reduced Albuminuria in T2D Patients With Heart Riskѻý> Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
<ѻý>Is Diabetes a Risk Factor for Long COVID? Possibly.ѻý> Mixed results in seven-study scoping review Jun 05, 2022
<ѻý>Dulaglutide Improves HbA1c for Youth With Type 2 Diabetesѻý> Safety profile consistent with that reported in adults Jun 05, 2022
<ѻý>Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesityѻý> SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
<ѻý>Sugar-Sweetened Beverage Taxes Cut Sales by 15%ѻý> However, evidence of tax undershifting was apparent Jun 01, 2022
<ѻý>No Cardioprotection Seen With Long-Term Metformin or Lifestyle Interventionѻý> Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
<ѻý>SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin?ѻý> Observational study suggests some cardiovascular benefit May 23, 2022
<ѻý>Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulationѻý> Trial followed patients with Senza System for 18 months May 16, 2022
<ѻý>Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomesѻý> Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
<ѻý>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetesѻý> Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<ѻý>GIP/GLP-1 Receptor Agonist Slashes Body Weight by More Than 20%ѻý> "Impressive" topline results from trial in adults with overweight, obesity without diabetes May 02, 2022